The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $71.79

Today's change0.00 0.00%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $71.79

Today's change0.00 0.00%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.

AstraZeneca PLC closed at (U.S.)$71.79.

Over the last five days, shares have gained 0.66%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 8.17% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $71.79
  • High--
  • Low--
  • Bid / Ask(U.S.) $71.30 / (U.S.) $71.34
  • YTD % change+2.00%
  • Volume27,347
  • Average volume (10-day)1,228,579
  • Average volume (1-month)1,083,194
  • Average volume (3-month)1,539,819
  • 52-week range(U.S.) $64.26 to (U.S.) $82.68
  • Beta0.57
  • Trailing P/E73.58×
  • P/E 1 year forward17.09×
  • Forward PEG5.60×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield3.90%
  • Trailing EPS(U.S.) $0.98
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue6,6836,5426,4546,416
Total other revenue--------
Total revenue6,6836,5426,4546,416
Gross profit5,0515,1845,1735,098
Total cost of revenue1,6321,3581,2811,318
Total operating expense7,0326,0015,3455,580
Selling / general / administrative3,0662,7672,6502,436
Research & development1,3601,2751,2081,098
Depreciation / amortization306342267267
Interest expense (income), net operating--------
Unusual expense (income)1,027515417677
Other operating expenses, total-359-256-478-216
Operating income-3495411,109836
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-580322866638
Income after tax-321253797506
Income tax, total-2596969132
Net income-321254796504
Total adjustments to net income--------
Net income before extra. items-321254796504
Minority interest01-1-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-321254796504
Inc. avail. to common incl. extra. items-321254796504
Diluted net income-321254796504
Dilution adjustment--------
Diluted weighted average shares1,2621,2641,2641,262
Diluted EPS excluding extraordinary itemsvalue per share-0.250.200.630.40
Dividends per sharevalue per share0.900.001.900.00
Diluted normalized EPSvalue per share0.820.781.121.10